Cargando…

The protective effect of rheumatic disease agents in COVID-19

Several immunosuppressive therapies have been investigated as potential treatments for patients with severe and critical coronavirus disease 2019 (COVID-19). Notable examples include corticosteroids, interleukin 6 (IL-6), interleukin 1 (IL-1), Janus kinase (JAK), and tumor necrosis factor alpha (TNF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valenzuela-Almada, María O., Putman, Michael S., Duarte-García, Alí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	3
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833968/ https://www.ncbi.nlm.nih.gov/pubmed/33526326 http://dx.doi.org/10.1016/j.berh.2021.101659

Ejemplares similares

Telemedicine and current clinical practice trends in the COVID-19 pandemic
por: Wahezi, Sayed E., et al.
Publicado: (2021)

Réponse vaccinale contre la Covid en transplantation pulmonaire
por: Dauriat, G., et al.
Publicado: (2022)

Effect of passive immunization on immunogenicity and protective efficacy of vaccination against a Mexican low‐pathogenic avian H5N2 influenza virus
por: Forrest, Heather L., et al.
Publicado: (2013)

Reducing the risk of infection to patients and staff during gynaecological outpatient and ambulatory appointments
por: Farmer, Natalie, et al.
Publicado: (2021)

Vaccines - safety in pregnancy
por: Arora, Mala, et al.
Publicado: (2021)

Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation
por: Harling, Leanne, et al.
Publicado: (2017)

Improving musculoskeletal health for children and young people – A ‘call to action’
por: Foster, Helen E., et al.
Publicado: (2020)

COVID-19 in rheumatic disease patients on immunosuppressive agents
por: Sharmeen, Saika, et al.
Publicado: (2020)

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats
por: Kamphuis, Tobias, et al.
Publicado: (2013)

Radioprotection calculations for the EURISOL-DS direct target irradiation program at PSI
por: Zanini, L
Publicado: (22/0)

Baseline parameters – 05/27/2005 Eurisol-DS task #3 “100kW direct target station”
por: Stora, T
Publicado: (23/0)

W converter - BeO dual target prototype for 6He production - a preliminary note
por: Stora, T, et al.
Publicado: (23/1)

Online tests of a high power solid Al2O3 EURISOL target prototype
por: Fernandes, S, et al.
Publicado: (24/0)

First negative halogen beams produced at PSBooster-ISOLDE
por: Stora, T, et al.
Publicado: (22/0)

Feasibility of High Power Refractory Metal-Foil Targets for EURISOL
por: Wilfinger, R, et al.
Publicado: (2007)

Optimization of 6He production using W or Ta converter surrounded by BeO target assembly
por: N. Thiollieres, J.C. David, V. Blideanu, D. Dore, B. Rapp, D. Ridikas
Publicado: (23/1)

Feasibility study for the 100kW direct targets
por: T. Stora, J. Lettry, R. Catherall, E. Noah, R. Wilfinger, L. Penescu, E. Bouquerel, S. Fernandes, M. Santana-Leitner, L. Zanini, I. Guenter, F. Groeschel
Publicado: (23/1)

Engineering aspects for the EURISOL 100kW liquid metal targets
por: E. Noah
Publicado: (10/0)

EURISOL High Power Oxide Target Tests at TRIUMF
por: E. Bouquerel, L. Bruno, J. Lettry, E. Noah, L. Penescu1, T. Stora, R. Wilfinger
Publicado: (10/0)

picture of the bivalve prototype
por: Task3 members
Publicado: (07/0)

Design and test of a two-body target unit for 100kW solid targets
por: E. Bouquerel, R. Catherall, J. Lettry, S. Marzari, E. Noah, L. Penescu, T. Stora, R. Wilfinger and the ISOLDE collaboration
Publicado: (07/0)

Diffusion studies in prospective polycrystalline silicon carbide target materials for radioactive ion beam production at CERN-ISOLDE
por: S. Fernandes, R. Catherall, G. Izquierdo, J. Lettry, M. Menna, S. Sgobba, T. Stora
Publicado: (10/0)

picture of SiC334 target unit
por: Task#3 members
Publicado: (11/0)

Considerations on the proton beam shape for Refractory Metal Foil Targets
por: R. Wilfinger, L .Bruno
Publicado: (11/0)

TARPIPE Final report
por: E. Noah et al. CERNI. Gunter et al., PSI
Publicado: (24/0)

Final Report on TARPIPE- Deliverable D2
por: E. Noah, E. Bouquerel, V. Boutellier, R. Bruetsch, R. Catherall, S. Fernandes, I. Guenther-Leopold, F. Groeschel, A. Kalt, J. Lettry, E. Manfrin, S. Marzari, T. Stora, W. Wagner, R. Wilfinger, L. Zanini
Publicado: (14/0)

Final report on oxide target prototype - Deliverable D3
por: S. Fernandes, E. Bouquerel, L. Bruno, R. Catherall, T. Giles, P. Kasprowicz, J. Lettry, S. Marzari, E. Noah, T. Stora, P. Bricault, M. Dombsky, F. Ames
Publicado: (14/0)

D5-Comparison of targets
por: T. Stora, P. Bricault, L. Bruno, S. Fernandes, F. Gröschel, I. Günther, J. Lettry, M. Loiselet, E. Noah, E. Platacis, L. Zanini
Publicado: (05/1)

Alkali suppression for pure Radioactive Ion Beam (RIB) production
por: E. Bouquerel, R. Catherall, M. Eller, J. Lettry, S. Marzari, T. Stora and the ISOLDE
Publicado: (22/0)

TARPIPE: TARget Prototype Irradiations at PSI for EURISOL
por: E. Bouquerel1, R. Catherall1, S. Fernandes1, I. Guenther-Leopold2, F. Groeschel2, A. Kalt2, J.
Publicado: (22/0)

Feasibility of High Power Refractory Metal Foil-Targets for EURISOL
por: R. Wilfinger, J. Lettry and the EURISOL Task 3 Workgroup
Publicado: (04/0)

Calculation of Production and Decay of Radio Isotopes for Future Irradiation Experiments and Ion Bea
por: M. Eller, J. Lettry, R. Catherall, T. Stora
Publicado: (04/0)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
por: Budimir, Natalija, et al.
Publicado: (2013)

La cinétique des D-dimères pendant l'hospitalisation est un facteur pronostique majeur de décès chez les patients hospitalisés pour COVID-19
por: Julien, M., et al.
Publicado: (2022)

Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
por: Santos, Cristiana Sieiro, et al.
Publicado: (2021)

Design cas témoins apparié sur score de risque : un outil méthodologique original pour une étude de l'efficacité vaccinale et des conséquences médicales de l'hospitalisation pour COVID-19 en France.
por: Semenzato, L., et al.
Publicado: (2023)

Nursing interventions to the person with cardiac disease submitted to ECMO – integrative literature review
por: Reisinho, João, et al.
Publicado: (2021)

Seasonal influenza vaccine effectiveness among children, 2010–2012
por: Fu, Chuanxi, et al.
Publicado: (2013)

32 COVID-19 and new hypertensive disease in pregnancy
por: Madden, Nigel, et al.
Publicado: (2021)

Measured and genetic LDL-C and the risk of incident atrial fibrillation
por: Park, H, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uo6qmbijvcjcajfmlea53ueup2